Signaling pathways in vascular development

Annual Review of Cell and Developmental Biology

Volumn 18, Issue , 2002, Pages 541-573

  Rossant, Janet ^a   Howard, Lorraine ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Angiogenesis; Artery; Signaling; Vasculogenesis; Vein

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOPOIETIN; EPHRIN; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN; GROWTH PROMOTOR;

ANGIOGENESIS; CELL POLARITY; CELL SPECIFICITY; DRUG TARGETING; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE ACTIVITY; GENE FUNCTION; GENE INDUCTION; GENE MUTATION; ISCHEMIA; ISCHEMIC HEART DISEASE; NIDATION; NONHUMAN; NUTRIENT; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; ANIMAL; BLOOD VESSEL; CYTOLOGY; EMBRYO; GENETICS; HUMAN; MAMMAL; METABOLISM; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MAMMALIA;

ANIMALS; BLOOD VESSELS; BODY PATTERNING; EMBRYO; GROWTH SUBSTANCES; HUMANS; ISCHEMIA; MAMMALS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 0036439461     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.18.012502.105825     Document Type: Review

References (206)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, et al. 1998. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA 95:548-53
2. Adams RH, Diella F, Hennig S, Helmbacher F, Deutsch U, Klein R. 2001. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 104:57-69
3. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, et al. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13: 295-306
4. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. 1989. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 86:4544-48
5. Artavanis-Tsakonas S, Rand MD, Lake RJ. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284:770-76
6. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, et al. 2000. Endoglin, an ancillary TGF-beta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev. Biol. 217:42-53
7. Azuma H. 2000. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J. Med. Invest. 47:81-90
8. Baird A, Durkin T. 1986. Inhibition of endothelial cell proliferation by type beta-transforming growth factor: Interactions with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Commun. 138:476-82
9. Barbara NP, Wrana JL, Letarte M. 1999. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J. Biol. Chem. 274:584-94
10. Betsholtz C, Karlsson L, Lindahl P. 2001. Developmental roles of platelet-derived growth factors. BioEssays 23:494-507
11. Bourdeau A, Dumont DJ, Letarte M. 1999. A murine model of hereditary hemorrhagic telangiectasia. J. Clin. Invest. 104:1343-51
12. Byrd N, Becker S, Maye P, Narasimhaiah R, St-Jacques B, et al. 2002. Hedgehog is required for murine yolk sac angiogenesis. Development 129:361-72
13. Carmeliet P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389-95
14. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, et al. 1998. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485-90. Erratum. 1998. Nature 395(6701):525
15. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-39
16. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, et al. 2001. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7:575-83
17. Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, et al. 1999. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat. Med. 5:495-502
18. Castella P, Sawai S, Nakao K, Wagner JA, Caudy M. 2000. HES-1 repression of differentiation and proliferation in PC12 cells: Role for the helix 3-helix 4 domain in transcription repression. Mol. Cell. Biol. 20:6170-83
19. Cau E, Gradwohl G, Casarosa S, Kageyama R, Guillemot F. 2000. Hes genes regulate sequential stages of neurogenesis in the olfactory epithelium. Development 127:2323-32
20. Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M. 1997. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19:547-59
21. Chen YG, Hata A, Lo RS, Wotton D, Shi Y, et al. 1998. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12:2144-52
22. Cheng N, Brantley DM, Chen J. 2002. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 13:75-85
23. Childs S, Chen JN, Garrity DM, Fishman MC. 2002. Patterning of angiogenesis in the zebrafish embryo. Development 129:973-82
24. Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. 1998. A common precursor for hematopoietic and endothelial cells. Development 125:725-32
25. Clauss M, Weich H, Breier G, Knies U, Rockl W, et al. 1996. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271:17629-34
26. Cleaver O, Krieg PA. 1998. VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development 125:3905-14
27. Conlon RA, Reaume AG, Rossant J. 1995. Notch1 is required for the coordinate segmentation of somites. Development 121: 1533-45
28. Conway EM, Collen D, Carmeliet P. 2001. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49:507-21
29. Cox CM, Poole TJ. 2000. Angioblast differentiation is influenced by the local environment: FGF-2 induces angioblasts and patterns vessel formation in the quail embryo. Dev. Dyn. 218:371-82
30. Davis RL, Turner DL. 2001. Vertebrate hairy and Enhancer of split related proteins: Transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 20:8342-57
31. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, et al. 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-69
32. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, et al. 1994. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266:816-19
33. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, et al. 1998. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 111:1-6
34. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121:1845-54
35. Drake CJ, Hungefford JE, Little CD. 1998. Morphogenesis of the first blood vessels. Ann. NY Acad. Sci. 857:155-79
36. Drake CJ, Little CD. 1995. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad. Sci. USA 92:7657-61
37. Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML. 1995. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 203:80-92
38. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, et al. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1897-909
39. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, et al. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-49
40. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. 1992. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7:1471-80
41. Dunker N, Krieglstein K. 2000. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 267:6982-88
42. Dyer MA, Farrington SM, Mohn D, Munday JR, Baron MH. 2001. Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 128:1717-30
43. Eichmarm A, Corbel C, Nataf V, Vaigot P, Breant C, Le Douarin NM. 1997. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor2. Proc. Natl. Acad. Sci. USA 94:5141-46
44. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, et al. 1991. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66:649-61
45. Elson DA, Thurston G, Huang LE, Ginzinger DG, McDonald DM, et al. 2001. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 15:2520-32
46. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. 1998. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140:947-59
47. Ferrara N, Alitalo K. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5:1359-64
48. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, et al. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-42
49. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr. Rev. 18:4-25
50. Flanagan JG, Vanderhaeghen P. 1998. The ephrins and Eph receptors in neural development. Annu. Rev. Neurosci. 21:309-45
51. Folkman J, D'Amore PA. 1996. Blood vessel formation: What is its molecular basis? Cell 87:1153-55
52. Fong GH, Rossant J, Gertsenstein M, Breitman ML. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70
53. Fong GH, Zhang L, Bryce DM, Peng J. 1999. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126:3015-25
54. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-13
55. Fortini ME, Artavanis-Tsakonas S. 1994. The suppressor of hairless protein participates in notch receptor signaling. Cell 79:273-82
56. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, et al. 1993. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75:681-92
57. Frater-Schroder M, Muller G, Birchmeier W, Bohlen P. 1986. Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137:295-302
58. Fuh G, Garcia KC, de Vos AM. 2000. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J. Biol. Chem. 275:26690-95
59. Gajdusek CM, Luo Z, Mayberg MR. 1993. Basic fibroblast growth factor and transforming growth factor beta-1: Synergistic mediators of angiogenesis in vitro. J. Cell. Physiol. 157:133-44
60. Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, et al. 1996. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17:9-19
61. Gale NW, Yancopoulos GD. 1997. Ephrins and their receptors: A repulsive topic? Cell Tissue Res. 290:227-41
62. Gale NW, Yancopoulos GD. 1999. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13:1055-66
63. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, et al. 1999. VEGF is required for growth and survival in neonatal mice. Development 126:1149-59
64. Gerety SS, Anderson DJ. 2002. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 129:1397-410
65. Gerety SS, Wang HU, Chen ZF, Anderson DJ. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell 4:403-14
66. Giger RJ, Urquhart ER, Gillespie SK, Levengood DV, Ginty DD, Kolodkin AL. 1998. Neuropilin-2 is a receptor for semaphorin IV: Insight into the structural basis of receptor function and specificity. Neuron 21:1079-92
67. Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G. 2000. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J. Biol. Chem. 275:18040-45. Erratum 2000. J. Biol. Chem. 275:29922
68. Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G. 2001. Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J. Biol. Chem. 276:18688-94
69. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78:1385-94
70. Grunstein J, Roberts WG, Mathieu-Costello O, Hanahan D, Johnson RS. 1999. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 59:1592-98
71. Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-64
72. He Z, Tessier-Lavigne M. 1997. Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90:739-51
73. Helbling PM, Saulnier DM, Brandli AW. 2000. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. Development 127:269-78
74. Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C. 1999. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047-55
75. Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, et al. 1996. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86:35-46
76. Henkemeyer M, Rossi DJ, Holmyard DP, Puri MC, Mbamalu G, et al. 1995. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377:695-701
77. Herzog Y, Kalcheim C, Kahane N, Reshef R, Neufeld G. 2001. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech. Dev. 109:115-19
78. Hidaka M, Stanford WL, Bernstein A. 1999. Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells. Proc. Natl. Acad. Sci. USA 96:7370-75
79. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. 1998. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95:9349-54
80. Holder N, Klein R. 1999. Eph receptors and ephrins: Effectors of morphogenesis. Development 126:2033-44
81. Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. 1996. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383:722-25
82. Hoodless PA, Wrana JL. 1998. Mechanism and function of signaling by the TGF beta superfamily. Curr. Top. Microbiol. Immunol. 228:235-72
83. Hrabe de Angelis M, McIntyre J 2nd, Gossler A. 1997. Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 386:717-21
84. Iruela-Arispe ML, Sage EH. 1993. Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-beta 1. J. Cell. Biochem. 52:414-30
85. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12:149-62
86. Jarecki J, Johnson E, Krasnow MA. 1999. Oxygen regulation of airway branching in Drosophila is mediated by branchless FGF. Cell 99:211-20
87. Jones N, Dumont DJ. 2000. Tek/Tie2 signaling: New and old partners. Cancer Metastasis Rev. 19:13-17
88. Jones N, Master Z, Jones J, Bouchard D, Gunji Y, et al. 1999. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J. Biol. Chem. 274:30896-905
89. Joseph-Silverstein J, Rifkin DB. 1987. Endothelial cell growth factors and the vessel wall. Semin. Thromb. Hemost. 13:504-13
90. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, et al. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15:290-98. Erratum. 1996. EMBO J. 15(7):1751
91. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, et al. 1996. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707-10
92. Joutel A, Toumier-Lasserve E. 1998. Notch signalling pathway and human diseases. Semin. Cell Dev. Biol. 9:619-25
93. Kabmn N, Buhring HJ, Choi K, Ullrich A, Risau W, Keller G. 1997. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 124:2039-48
94. Kageyama R, Ohtsuka T. 1999. The Notch-Hes pathway in mammalian neural development. Cell Res. 9:179-88
95. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, et al. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 92:3566-70
96. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. 1999. Regulation of the hypoxia-inducible transcription factor lalpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274:6519-25
97. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, et al. 1999. A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895-902
98. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, et al. 1989. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246:1309-12
99. Kitsukawa T, Shimono A, Kawakami A, Kondoh H, Fujisawa H. 1995. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 121:4309-18
100. Kojika S, Griffin JD. 2001. Notch receptors and hematopoiesis. Exp. Hematol. 29:1041-52
101. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. 1997. Neuropilin is a semaphorin m receptor. Cell 90:753-62
102. Korhonen J, Polvi A, Partanen J, Alitalo K. 1994. The mouse tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis. Oncogene 9:395-403. Erratum. 1996. Oncogene 12(4):943
103. Kozak KR, Abbott B, Hankinson O. 1997. ARNT-deficient mice and placental differentiation. Dev. Biol. 191:297-305
104. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, et al. 2000. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14:1343-52
105. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, et al. 1996. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 122:3829-37
106. Kuzuya M, Kinsella JL. 1994. Reorganization of endothelial cord-like structures on basement membrane complex (Matrigel): Involvement of transforming growth factor beta 1. J. Cell. Physiol. 161:267-76
107. Larcher F, Murillas R, Bolontrade M, Conti CJ, Jorcano JL. 1998. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 17:303-11
108. Larsson J, Goumans MJ, Sjostrand LI, van Rooijen MA, Ward D, et al. 2001. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20:1663-73
109. Lawson ND, Scheer N, Pham VN, Kim CH, Chimis AB, et al. 2001. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128:3675-83
110. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, et al. 2001. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412:877-84
111. Letamendia A, Lastres P, Botella LM, Raab U, Langa C, et al. 1998. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J. Biol. Chem. 273:33011-19
112. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Spore MB, Roberts AB. 1994. Maternal rescue of transforming growth factor-beta 1 null mice. Science 264:1936-38
113. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-9
114. Li C, Guo B, Bernabeu C, Kumar S. 2001. Angiogenesis in breast cancer: The role of transforming growth factor beta and CD105. Microsc. Res. Tech. 52:437-49
115. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, et al. 1999. Defective angiogenesis in mice lacking endoglin. Science 284:1534-37
116. Li L, Krantz ID, Deng Y, Genin A, Banta AB, et al. 1997. Alagille syndrome is caused by mutations in human Jaggedl, which encodes a ligand for Notchl. Nat. Genet. 16:243-51
117. Lindahl P, Hellstrom M, Kalen M, Betsholtz C. 1998a. Endothelial-perivascular cell signaling in vascular development: Lessons from knockout mice. Curt. Opin. Lipidol. 9:407-11
118. Lindahl P, Hellstrom M, Kalen M, Karlsson L, Pekny M, et al. 1998b. Paracrine PDGFB/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 125:3313-22
119. Lindahl P, Johansson BR, Leveen P, Betsholtz C. 1997. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277:242-45
120. Loughna S, Sato TN. 2001a. Angiopoietin and Tie signaling pathways in vascular development. Matrix Biol. 20:319-25
121. Loughna S, Sato TN. 2001b. A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis. Mol. Cell. 7:233-39
122. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
123. Maltepe E, Schmidt IV, Baunoch D, Bradfield CA, Simon MC. 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386:403-7
124. Matsumoto T, Claesson-Welsh L. 2001. VEGF receptor signal transduction. Sci. Signal Transd. Knowl. Environ. 2001:RE21
125. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, et al. 1999. The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis. Nature 399:271-75
126. Meirer R, Gurunluoglu R, Siemionow M. 2001. Neurogenic perspective on vascular endothelial growth factor: Review of the literature. J. Reconstr. M icrosurg. 17:625-30
127. Metzger RJ, Krasnow MA. 1999. Genetic control of branching morphogenesis. Science 284:1635-39
128. Migdal M, Huppertz B, Tessler S, Comforti A, Shibuya M, et al. 1998. Neuropilin-1 is aplacenta growth factor-2 receptor. J. Biol. Chem. 273:22272-78
129. Millauer B, Wizigrnann-Voos S, Schnurch H, Martinez R, Moller NP, et al. 1993. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-46
130. Miquerol L, Langille BL, Nagy A. 2000. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127:3941-46
131. Miyazono K, Kusanagi K, Inoue H. 2001. Divergence and convergence of TGF-beta/BMP signaling. J. Cell. Physiol. 187:265-76
132. Mummery CL. 2001. Transforming growth factor beta and mouse development. Microsc. Res. Tech. 52:374-86
133. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. 1993. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424-28
134. Nakagawa O, McFadden DG, Nakagawa M, Yanagisawa H, Hu T, et al. 2000. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc. Natl. Acad. Sci. USA 97:13655-60
135. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9-22
136. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y. 2002. The neuropilins: Multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12:13-19
137. Nye JS, Kopan R. 1995. Developmental signaling. Vertebrate ligands for Notch. Curr. Biol. 5:966-69
138. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, et al. 1997. Mutations in the human Jaggedl gene are responsible for Alagille syndrome. Nat. Genet. 16:235-42
139. Ogunshola OO, Antic A, Donoghue MJ, Fan SY, Kim H, et al. 2002. Paracrine and autocrine functions of neuronal VEGF in the CNS. Biol. Chem. 277:11410-15
140. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, et al. 2000. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97:2626-31
141. Orioli D, Klein R. 1997. The Eph receptor family: Axonal guidance by contact repulsion. Trends Genet. 13:354-59
142. Oshima M, Oshima H, Taketo MM. 1996. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179:297-302
143. Panchenko MP, Williams MC, Brody JS, Yu Q. 1996. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels. Am. J. Physiol. Lung Cell Mol. Physiol. 270:L547-L58
144. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, et al. 2000. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem. 275:9102-5
145. Pardanaud L, Luton D, Prigent M, Bourcheix LM, Catala M, Dieterlen-Lievre F. 1996. Two distinct endothelial lineages in ontogeny, one of them related to hemopoiesis. Development 122:1363-71
146. Partanen J, Dumont DJ. 1999. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. Curr. Top. Microbiol. Immunol. 237:159-72
147. Partanen J, Puff MC, Schwartz L, Fischer KD, Bernstein A, Rossant J. 1996. Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development 122:3013-21
148. Pepper MS. 1997. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8:21-43
149. Petrova TV, Makinen T, Alitalo K. 1999. Signaling via vascular endothelial growth factor receptors. Exp. Cell Res. 253:117-30
150. Piccoli DA, Spinner NB. 2001. Alagille syndrome and the Jagged1 gene. Semin. Liver Dis. 21:525-34
151. Procopio WN, Pelavin PI, Lee WM, Yeilding NM. 1999. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, hut fibrinogen-like domains mediate ligand activity. Biol. Chem. 274:30196-201
152. Puff MC, Partanen J, Rossant J, Bernstein A. 1999. Interaction of the TEK and TIE receptor kinases during cardiovascular development. Development 126:4569-80
153. Puff MC, Rossant J, Alitalo K, Bernstein A, Partanen J. 1995. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14:5884-91
154. RayChaudhury A, D'Amore PA. 1991. Endothelial cell regulation by transforming growth factor-beta. J. Cell. Biochem. 47:224-29
155. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-74
156. Risau W, Flamme I. 1995. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11:73-91.
157. Robb L, Elefanty AG. 1998. The hemangioblast-an elusive cell captured in culture. BioEssays 20:611-14
158. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, et al. 1986. Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83:4167-71
159. Roberts WG, Palade GE. 1997. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57:765-72
160. Robinson CJ, Stringer SE. 2001. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114:853-65
161. Roelen BA, van Rooijen MA, Mummery CL. 1997. Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev. Dyn. 209: 418-30
162. Ruchoux MM, Maurage CA. 1997. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoen-cephalopathy. J. Neuropathol. Exp. Neurol. 56:947-64
163. Ryan HE, Lo J, Johnson RS. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17: 3005-15
164. Sato TN, Qin Y, Kozak CA, Audus KL. 1993. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA 90:9355-58. Erratum. 1993. Proc. Natl. Acad. Sci. USA 90(24): 12056
165. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, et al. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74
166. Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M. 1996. Flt-1 but not KDR/Flt-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor, Cell Growth Differ. 7:213-21
167. Schnurch H, Risau W. 1993. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119:957-68
168. Schroeter EH, Kisslinger JA, Kopan R. 1998. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393:382-86
169. Schuh AC, Faloon P, Hu QL, Bhimani M, Choi K. 1999. In vitro hematopoietic and endothelial potential of flk-1(-/-) embryonic stem cells and embryos. Proc. Natl. Acad. Sci. USA 96:2159-64
170. Schwarte-Waldhoff I, Volpert OV, Bouck NP, Sipos B, Hahn SA, et al. 2000. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc. Natl. Acad. Sci. USA 97:9624-29
171. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15:551-78
172. Shalaby F, Ho J, Stanford WL, Fischer KD, Schuh AC, et al. 1997. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 89:981-90
173. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, et al. 1995. Failure of blood-island formation and vasculogenesis in Flk1-deficient mice. Nature 376:62-66
174. Shima DT, Kuroki M, Deutsch U, Ng YS, Adamis AP, D'Amore PA. 1996. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271:3877-83
175. Shima DT, Mailhos C. 2000. Vascular developmental biology: Getting nervous. Curr. Opin. Genet. Dev. 10:536-42
176. Shirayoshi Y, Yuasa Y, Suzuki T, Sugaya K, Kawase E, et al. 1997. Proto-oncogene of int-3, a mouse Notch homologue, is expressed in endothelial cells during early embryogenesis. Genes Cells 2:213-24
177. Shutter JR, Scully S, Fan W, Richards WG, Kitajewski J, et al. 2000. Dl14, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 14:1313-18
178. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. 1993. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 91:2235-43
179. Soker S, Takashirna S, Miao HQ, Neufeld G, Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor ceils as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-45
180. Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, et al. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109:327-36
181. Steneberg P, Hemphala J, Samakovlis C. 1999. Dpp and Notch specify the fusion ceil fate in the dorsal branches of the Drosophila trachea. Mech. Dev. 87:153-63
182. Struhl G, Adachi A. 1998. Nuclear access and action of notch in vivo. Cell 93:649-60
183. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, et al. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-80
184. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, et al. 1998.
185. Sutton AB, Canfield AE, Schor SL, Grant ME, Schor AM. 1991. The response of endothelial cells to TGF beta-1 is dependent upon cell shape, proliferative state and the nature of the substratum. J. Cell Sci. 99:777-87
186. Takashima S, Kitakaze M, Asakura M, Asanuma H, Sanada S, et al. 2002. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA 99:3657-62
187. Thurston G, Suri C, Smith K, McClain J, Sato TN, et al. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-14
188. Urness LD, Sorensen LK, Li DY. 2000. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat. Genet. 26:328-31
189. Uyttendaele H, Ho J, Rossant J, Kitajewski J. 2001. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl. Acad. Sci. USA 98:5643-48
190. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J. 1996. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122:2251-59
191. Uyttendaele H, Soriano IV, Montesano R, Kitajewski J. 1998. Notch4 and Wnt-1 proteins function to regulate branching morphogenesis of mammary epithelial cells in an opposing fashion. Dev. Biol. 196:204-17
192. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, et al. 1999. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA 96:1904-9
193. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G. 2001. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev. 108:161-64
194. 2 tension. Proc. Natl. Acad. Sci. USA 92:5510-14
195. Wang H, Chen Z, Anderson D. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-53
196. Whitaker GB, Limberg B J, Rosenbaum JS. 2001. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). J. Biol. Chem. 276:25520-31
197. Xu Q, Wilkinson DG. 1997. Eph-related receptors and their ligands: Mediators of contact dependent ceil interactions. J. Mol. Med. 75:576-86
198. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, et al. 1999. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 8:723-30
199. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. 1993. flk-1, an fit-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118:489-98
200. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, et al. 2000. Flkl-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96
201. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand S J, Holash J. 2000. Vascular-specific growth factors and blood vessel formation. Nature 407:242-48
202. Yang EY, Moses HL. 1990. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111:731-41
203. Yang K, Cepko CL. 1996. Flk-1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J. Neurosci. 16:6089-99
204. Yang X, Castilla LH, Xu X, Li C, Gotay J, et al. 1999. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126:1571-80
205. Zhong TP, Childs S, Leu JP, Fishman MC. 2001. Gridlock signalling pathway fashions the first embryonic artery. Nature 414:216-20
206. Zhong TP, Rosenberg M, Mohideen MA, Weinstein B, Fishman MC. 2000. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287:1820-24